Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

[A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].

Asmarin IP, Nezavibat'ko VN, Miasoedov NF, Kamenskiĭ AA, Grivennikov IA, Ponomareva-Stepnaia MA, Andreeva LA, Kaplan AIa, Koshelev VB, Riasina TV.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1997 Mar-Apr;47(2):420-30. Russian.

PMID:
9173745
2.

[Nootropic and analgesic effects of Semax following different routes of administration].

Manchenko DM, Glazova NIu, Levitskaia NG, Andreeva LA, Kamenskiĭ AA, Miasoedov NF.

Ross Fiziol Zh Im I M Sechenova. 2010 Oct;96(10):1014-23. Russian.

PMID:
21268834
4.

[Effect of modification of the N-terminal region of molecule on the expression of neotropic effect of semax analogues].

Glazova NIu, Sebentsova EA, Levitskaia NG, Andreeva LA, Alfeeva LIu, Kamenskiĭ AA, Miasoedov NF.

Izv Akad Nauk Ser Biol. 2005 Jul-Aug;(4):460-6. Russian.

PMID:
16212268
5.

Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.

Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, Dubynina EV, Novosadova EV, Andreeva LA, Alfeeva LY, Kamensky AA, Grivennikov IA, Myasoedov NF, Engele J.

Brain Res. 2006 Oct 30;1117(1):54-60. Epub 2006 Sep 22.

PMID:
16996037
6.
7.

[Effects of semax and ACTH(5-10) on the impulse activity of central neurons].

Iasnetsov VV, Pravdivtsev VA, Krylova IN, Kozlov SB, Provornova NA.

Biull Eksp Biol Med. 1998 Mar;125(3):304-6. Russian. No abstract available.

PMID:
9606550
8.

[Dependence of long-lasting effects of the ACTH(4-10) analogue semax on the time of its neonatal administration].

Sebentsova EA, Glazova NIu, Levitskaia NG, Andreeva LA, Alfeeva LIu, Kamenskiĭ AA, Miasoedov NF.

Ross Fiziol Zh Im I M Sechenova. 2005 Feb;91(2):122-31. Russian.

PMID:
15835535
9.

[Chronotropic activity of semax].

Arushanian EB, Popov AV.

Eksp Klin Farmakol. 2008 Mar-Apr;71(2):14-6. Russian.

PMID:
18488900
10.

[An experimental substantiation for using the "Semax" neuroprotector in the treatment of optic-nerve diseases].

Sheremet NL, Polunin GS, Ovchinnikov AN, Kamenskiĭ AA, Levitskaia NG, Andreeva LA, Alfeeva LIu, Nagaev IIu.

Vestn Oftalmol. 2004 Nov-Dec;120(6):25-7. Russian.

PMID:
15678666
11.

The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo.

Dolotov OV, Seredenina TS, Levitskaya NG, Kamensky AA, Andreeva LA, Alfeeva LY, Nagaev IY, Zolotarev YA, Grivennikov IA, Engele Y, Myasoedov NF.

Dokl Biol Sci. 2003 Jul-Aug;391:292-5. No abstract available.

PMID:
14556513
12.

Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats.

Volodina MA, Sebentsova EA, Glazova NY, Levitskaya NG, Andreeva LA, Manchenko DM, Kamensky AA, Myasoedov NF.

Bull Exp Biol Med. 2012 Mar;152(5):560-3. English, Russian.

PMID:
22803132
13.

Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action.

Shadrina M, Kolomin T, Agapova T, Agniullin Y, Shram S, Slominsky P, Lymborska S, Myasoedov N.

J Mol Neurosci. 2010 May;41(1):30-5. doi: 10.1007/s12031-009-9270-z. Epub 2009 Aug 7.

PMID:
19662538
14.

Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS.

Neurochem Res. 2005 Dec;30(12):1493-500.

PMID:
16362768
15.

Trophic effects of nootropic peptide preparations cerebrolysin and semax on cultured rat pheochromocytoma.

Safarova ER, Shram SI, Grivennikov IA, Myasoedov NF.

Bull Exp Biol Med. 2002 Apr;133(4):401-3.

PMID:
12124658
16.

Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia.

Bashkatova VG, Koshelev VB, Fadyukova OE, Alexeev AA, Vanin AF, Rayevsky KS, Ashmarin IP, Armstrong DM.

Brain Res. 2001 Mar 9;894(1):145-9.

PMID:
11245825
17.

[Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency].

Gusev EI, Skvortsova VI, Chukanova EI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(2):35-40. Russian.

PMID:
15792140
18.

[Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system].

Levitskaia NG, Sebentsova EA, Andreeva LA, Alfeeva LIu, Kamenskiĭ AA, Miasoedov NF.

Ross Fiziol Zh Im I M Sechenova. 2002 Nov;88(11):1369-77. Russian.

PMID:
12587264
19.

[Effect of semax on heart rate variability in various daytime periods].

Arushanian EB, Popov AV.

Eksp Klin Farmakol. 2009 Mar-Apr;72(2):32-4. Russian.

PMID:
19441725
20.

Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain.

Dolotov OV, Karpenko EA, Seredenina TS, Inozemtseva LS, Levitskaya NG, Zolotarev YA, Kamensky AA, Grivennikov IA, Engele J, Myasoedov NF.

J Neurochem. 2006 Apr;97 Suppl 1:82-6.

Supplemental Content

Support Center